Year Established :
2016
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
100-500
Main Competitive Advantages :
International Approvals/Standards,Production Capacity,Large Product Line,Quality Service
Business Type :
Manufacturer
R&D Capacity :
Own Brand
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
Central/South America,Asia,Middle East
Product Range :
HUMAN API
LIDOCAINE HCL / BASE BP/USP
SILDENAFIL CITRATE / BASE USP / EP
GUAIFENESIN USP / BP / EP
METHOCARBAMOL USP T
BROMHEXINE BP / EP
DIPHENHYDRAMINE HCL BP
PREGABALIN USP
POVIDONE IODINE BP / USP
PIPERAZINE CITRATE BP / USP
PIPERAZINE DI HCL USP
DIETHYL CARBAMAZINE CITRATE USP
VALPROIC ACID BP / USP
VETERINARY API.
ROXARSONE USP
HALQUINOL 40%, 60% , 80% , 98% BP
OXYCLOZANIDE BP
RAFOXANIDE BP
TRICLABENDAZOLE BP / EP
OXFENDAZOLE USP / BP / EP
CLOSANTEL BASE INHOUSE
CLOSANTEL SODIUM BP
NITROXYNIL BP
FENBENDAZOLE USP / BP / EP
NICLOSAMIDE BP